BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22446103)

  • 61. The estrogen-regulated transcription factor PITX1 coordinates gene-specific regulation by estrogen receptor-alpha in breast cancer cells.
    Stender JD; Stossi F; Funk CC; Charn TH; Barnett DH; Katzenellenbogen BS
    Mol Endocrinol; 2011 Oct; 25(10):1699-709. PubMed ID: 21868451
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Arsenic induces functional re-expression of estrogen receptor α by demethylation of DNA in estrogen receptor-negative human breast cancer.
    Du J; Zhou N; Liu H; Jiang F; Wang Y; Hu C; Qi H; Zhong C; Wang X; Li Z
    PLoS One; 2012; 7(4):e35957. PubMed ID: 22558281
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-alpha-dependent and estrogen receptor-alpha-independent mechanisms.
    Long X; Fan M; Bigsby RM; Nephew KP
    Mol Cancer Ther; 2008 Jul; 7(7):2096-108. PubMed ID: 18645020
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Estrogen receptor-alpha phosphorylated at Ser118 is present at the promoters of estrogen-regulated genes and is not altered due to HER-2 overexpression.
    Weitsman GE; Li L; Skliris GP; Davie JR; Ung K; Niu Y; Curtis-Snell L; Tomes L; Watson PH; Murphy LC
    Cancer Res; 2006 Oct; 66(20):10162-70. PubMed ID: 17047081
    [TBL] [Abstract][Full Text] [Related]  

  • 65. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.
    Laganière J; Deblois G; Lefebvre C; Bataille AR; Robert F; Giguère V
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11651-6. PubMed ID: 16087863
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differential ERα-mediated rapid estrogenic actions of ginsenoside Rg1 and estren in human breast cancer MCF-7 cells.
    Gao QG; Chan HY; Man CW; Wong MS
    J Steroid Biochem Mol Biol; 2014 May; 141():104-12. PubMed ID: 24508513
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Estrogen receptor α regulates the expression of syndecan-1 in human breast carcinoma cells.
    Fleurot E; Goudin C; Hanoux V; Bonnamy PJ; Levallet J
    Endocr Relat Cancer; 2019 Jun; 26(6):615-628. PubMed ID: 30978702
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters.
    Kininis M; Chen BS; Diehl AG; Isaacs GD; Zhang T; Siepel AC; Clark AG; Kraus WL
    Mol Cell Biol; 2007 Jul; 27(14):5090-104. PubMed ID: 17515612
    [TBL] [Abstract][Full Text] [Related]  

  • 69. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.
    Woodfield GW; Horan AD; Chen Y; Weigel RJ
    Cancer Res; 2007 Sep; 67(18):8439-43. PubMed ID: 17875680
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A noncompetitive small molecule inhibitor of estrogen-regulated gene expression and breast cancer cell growth that enhances proteasome-dependent degradation of estrogen receptor {alpha}.
    Kretzer NM; Cherian MT; Mao C; Aninye IO; Reynolds PD; Schiff R; Hergenrother PJ; Nordeen SK; Wilson EM; Shapiro DJ
    J Biol Chem; 2010 Dec; 285(53):41863-73. PubMed ID: 21041310
    [TBL] [Abstract][Full Text] [Related]  

  • 71. RhoA and RhoC differentially modulate estrogen receptor α recruitment, transcriptional activities, and expression in breast cancer cells (MCF-7).
    Malissein E; Meunier E; Lajoie-Mazenc I; Médale-Giamarchi C; Dalenc F; Doisneau-Sixou SF
    J Cancer Res Clin Oncol; 2013 Dec; 139(12):2079-88. PubMed ID: 24096540
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
    Giulianelli S; Vaqué JP; Soldati R; Wargon V; Vanzulli SI; Martins R; Zeitlin E; Molinolo AA; Helguero LA; Lamb CA; Gutkind JS; Lanari C
    Cancer Res; 2012 May; 72(9):2416-27. PubMed ID: 22396492
    [TBL] [Abstract][Full Text] [Related]  

  • 73. AKT alters genome-wide estrogen receptor alpha binding and impacts estrogen signaling in breast cancer.
    Bhat-Nakshatri P; Wang G; Appaiah H; Luktuke N; Carroll JS; Geistlinger TR; Brown M; Badve S; Liu Y; Nakshatri H
    Mol Cell Biol; 2008 Dec; 28(24):7487-503. PubMed ID: 18838536
    [TBL] [Abstract][Full Text] [Related]  

  • 74. LSD1 engages a corepressor complex for the activation of the estrogen receptor α by estrogen and cAMP.
    Bennesch MA; Segala G; Wider D; Picard D
    Nucleic Acids Res; 2016 Oct; 44(18):8655-8670. PubMed ID: 27325688
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differential estradiol and selective estrogen receptor modulator (SERM) regulation of Keratin 13 gene expression and its underlying mechanism in breast cancer cells.
    Sheng S; Barnett DH; Katzenellenbogen BS
    Mol Cell Endocrinol; 2008 Dec; 296(1-2):1-9. PubMed ID: 18951949
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Estrogen inhibits transforming growth factor beta signaling by promoting Smad2/3 degradation.
    Ito I; Hanyu A; Wayama M; Goto N; Katsuno Y; Kawasaki S; Nakajima Y; Kajiro M; Komatsu Y; Fujimura A; Hirota R; Murayama A; Kimura K; Imamura T; Yanagisawa J
    J Biol Chem; 2010 May; 285(19):14747-55. PubMed ID: 20207742
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Proteasome inhibition represses ERalpha gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer.
    Powers GL; Ellison-Zelski SJ; Casa AJ; Lee AV; Alarid ET
    Oncogene; 2010 Mar; 29(10):1509-18. PubMed ID: 19946334
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Estrogen Enhances the Cell Viability and Motility of Breast Cancer Cells through the ERα-ΔNp63-Integrin β4 Signaling Pathway.
    Ho JY; Chang FW; Huang FS; Liu JM; Liu YP; Chen SP; Liu YL; Cheng KC; Yu CP; Hsu RJ
    PLoS One; 2016; 11(2):e0148301. PubMed ID: 26845172
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells.
    Miah S; Bagu E; Goel R; Ogunbolude Y; Dai C; Ward A; Vizeacoumar FS; Davies G; Vizeacoumar FJ; Anderson D; Lukong KE
    BMC Cancer; 2019 Jan; 19(1):78. PubMed ID: 30651078
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Induction of estrogen receptor α-36 expression by bone morphogenetic protein 2 in breast cancer cell lines.
    Wang D; Huang P; Zhu B; Sun L; Huang Q; Wang J
    Mol Med Rep; 2012 Sep; 6(3):591-6. PubMed ID: 22711074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.